NFA
VRTX icon

Nationwide Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Nationwide Fund Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-173,157
Closed -$26.3M – 2055
2017
Q3 		$26.3M Buy
173,157
+56,646
+49% +$8.53M 0.1% 215
2017
Q2 		$15M Sell
116,511
-5,407
-4% -$651K 0.06% 450
2017
Q1 		$13.3M Sell
121,918
-99,438
-45% -$8.75M 0.05% 510
2016
Q4 		$16.3M Sell
221,356
-40,925
-16% -$3.33M 0.07% 386
2016
Q3 		$22.9M Buy
262,281
+154,249
+143% +$14.6M 0.1% 240
2016
Q2 		$9.29M Buy
108,032
+8,421
+8% +$728K 0.04% 609
2016
Q1 		$7.92M Sell
99,611
-33,234
-25% -$3.01M 0.03% 695
2015
Q4 		$16.7M Sell
132,845
-145,545
-52% -$17.6M 0.07% 353
2015
Q3 		$29M Sell
278,390
-9,280
-3% -$1.19M 0.13% 166
2015
Q2 		$35.5M Buy
287,670
+2,031
+0.7% +$256K 0.15% 141
2015
Q1 		$33.7M Sell
285,639
-39,078
-12% -$4.68M 0.14% 159
2014
Q4 		$38.6M Buy
324,717
+20,724
+7% +$2.33M 0.16% 129
2014
Q3 		$34.1M Sell
303,993
-26,123
-8% -$2.49M 0.14% 151
2014
Q2 		$31.3M Buy
330,116
+65,841
+25% +$4.62M 0.13% 186
2014
Q1 		$18.7M Sell
264,275
-5,854
-2% -$464K 0.09% 289
2013
Q4 		$20.1M Sell
270,129
-23,687
-8% -$1.65M 0.08% 286
2013
Q3 		$22.3M Sell
293,816
-189,679
-39% -$15.1M 0.1% 237
2013
Q2 		$38.6M Buy
+483,495
New +$35.6M 0.2% 84

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nationwide Fund Advisors's VRTX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q4 2017, closing a stake of 173,157 shares — an estimated $26.3M sold.

Nationwide Fund Advisors first reported a position in VRTX in Q2 2013 and held it in 18 quarters. The position peaked at $38.6M in Q2 2013. 644 funds tracked by Wall St. Rank hold VRTX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Vertex Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 173,157 Vertex Pharmaceuticals shares in Q4 2017, an estimated $26.3M.
  • Nationwide Fund Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Vertex Pharmaceuticals position peaked at $38.6M in Q2 2013.
  • 644 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.